Last updated on December 2017

A Phase 2a Randomized Double-blind Placebo Controlled Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention


Brief description of study

Protocol #: 20150308
Migraine prevention in Subjects with Chronic Migraine (CM) or Episodic Migraine (EM) comparing the treatment medication AMG 301 to placebo.

Clinical Study Identifier: TX154855

Find a site near you

Start Over

Texas Neurology, PA

6301 Gaston Avenue #100W Dallas, TX USA
  Connect »